The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArmadale Capital Regulatory News (ACP)

Share Price Information for Armadale Capital (ACP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.725
Bid: 0.70
Ask: 0.75
Change: 0.00 (0.00%)
Spread: 0.05 (7.143%)
Open: 0.725
High: 0.725
Low: 0.725
Prev. Close: 0.725
ACP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

11 Oct 2016 07:00

Armadale Capital Plc / Index: AIM / Epic: ACP / Sector: Investment Company

11 October 2016

Armadale Capital Plc (‘Armadale’ or ‘the Company’)

Issue of Equity

Armadale, the AIM quoted investment company focused on natural resource projects in Africa, announces that it has allotted 3,000,000 ordinary shares of 0.1p each in the capital of the Company (‘Ordinary Shares’) to two retiring directors in lieu of notice and 2,500,000 Ordinary Shares to drilling contractors, all at a deemed price of 3.75p per Ordinary Share.

William Frewen, Chairman of Armadale, said, “It is very encouraging to see that both retiring directors and drilling contractors have confidence in our future by taking shares in lieu of notice and fees. Having recently discovered high-grade coarse flake graphite mineralisation at the Mahenge Liandu Graphite Project in Tanzania, we believe this asset offers significant uplift potential and we look forward to building its value for the benefit of all stakeholders."

The Company has applied for admission of the 5,500,000 new Ordinary Shares to trading on AIM. Dealings are expected to become effective on 14 October 2016 (‘Admission’). Following Admission, the Company will have 208,501,967 Shares in issue with each Ordinary Share carrying the right to one vote. There are no Ordinary Shares currently held in treasury. The total number of voting rights in the Company therefore will be 208,501,967 and this figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Rules and Transparency Rules.

**ENDS**

Enquiries:
Armadale Capital Plc

Charles Zorab, Company Secretary

+44 20 7233 1462
Nomad and broker: finnCap Ltd

Christopher Raggett / Simon Hicks

+44 20 7220 0500
Joint Broker: Beaufort Securities Limited

Jon Belliss

+44 20 7382 8300
Press Relations: St Brides Partners Ltd

Charlotte Page / Susie Geliher

+44 20 7236 1177

Notes

Armadale Capital Plc is focused on investing in and developing a portfolio of investments, targeting the natural resources and/or infrastructure sectors in Africa. The Company, led by a team with operational experience and a strong track record in Africa, has a strategy of identifying high growth businesses where it can take an active role in their advancement.

More information can be found on the website www.armadalecapitalplc.com.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161010006095/en/

Copyright Business Wire 2016

Date   Source Headline
24th Apr 20248:30 amRNSProposed Investment, Subscription & Board Changes
27th Feb 20242:45 pmRNSMahenge Project Update
19th Dec 202311:15 amRNSBlock listing Interim Review
29th Sep 20237:00 amRNSHalf-year Report
20th Jun 202310:38 amRNSResult of AGM
19th Jun 20237:00 amRNSBlock listing Interim Review
12th May 20237:00 amRNSFinal Results and Notice of AGM
13th Feb 20239:00 amRNSMahenge Project Update
19th Dec 20227:00 amRNSBlock listing Interim Review
29th Sep 20227:00 amRNSHalf-year Report
20th Jun 202210:45 amRNSResult of AGM
17th Jun 20223:30 pmRNSBlock listing Interim Review
23rd May 20227:00 amRNSFinal Results and Notice of AGM
3rd May 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Apr 20227:00 amRNSIssue of Equity Under Block Admission Arrangements
17th Mar 20223:20 pmRNSHolding(s) in Company
11th Mar 20222:45 pmRNSDirector/PDMR Shareholding and TVR
8th Feb 20228:15 amRNSAdvancing Mining Lease and Expanded Footprint
17th Dec 20217:00 amRNSBlock listing Interim Review
15th Dec 20219:30 amRNSManagement Team Enhanced With Key Appointment
1st Dec 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Nov 20217:00 amRNSIssue of Equity Under Block Admission Arrangements
1st Oct 20217:00 amRNSIssue of equity under block admission arrangements
29th Sep 20217:00 amRNSHalf-year Report
3rd Sep 20219:00 amRNSMahenge Mining Licence Granted
31st Aug 20217:00 amRNSNotification of Changes in Major Holdings
6th Aug 20211:25 pmRNSConversion of Loan Notes and Director Shareholding
28th Jun 202112:40 pmRNSBlock Admission & TVR
28th Jun 202112:18 pmRNSAGM Statement
17th Jun 20217:00 amRNSBlock listing Interim Review
28th May 20213:45 pmRNSSubscription and Investment Portfolio Update
28th May 20213:18 pmRNSFinal Results And Notice of AGM
22nd Apr 202110:00 amRNSCompletion of Test Work Program
12th Apr 20219:20 amRNSChange of Adviser
30th Mar 20219:58 amRNSESIA Approval from NEMC of Tanzania
24th Mar 20217:35 amRNSBoard Change
8th Mar 202112:36 pmRNSNotification of Changes in Major Holdings
17th Feb 20214:41 pmRNSSecond Price Monitoring Extn
17th Feb 20214:35 pmRNSPrice Monitoring Extension
10th Feb 202111:00 amRNSArmadale Reports Successful Chinese EPC Test-Work
11th Jan 202111:00 amRNSCSIRO Graphite Test Work Results
17th Dec 20207:00 amRNSBlock listing Interim Review
24th Nov 202012:03 pmRNSTest-Work Commenced with Leading EPC Contractor
20th Nov 20204:41 pmRNSSecond Price Monitoring Extn
20th Nov 20204:36 pmRNSPrice Monitoring Extension
13th Oct 202010:00 amBUSMahenge Graphite Project Update
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:36 pmRNSPrice Monitoring Extension
29th Sep 20208:46 amBUSHalf-year Report
8th Sep 202012:45 pmBUSEnvironmental and Social Impact Assessment Submitted

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.